May 11, 2023 12:26 PM EDT
Manufacturing

Man­u­fac­tur­ing roundup: Qual­i­ty is­sues at Sun Phar­ma plant in In­dia; Forge se­cures gene ther­a­py man­u­fac­tur­ing con­tract

Tyler Patchen

News Reporter

The FDA has re­vealed fur­ther is­sues at a Sun Phar­ma man­u­fac­tur­ing fa­cil­i­ty in In­dia.

Last month, Sun Phar­ma an­nounced it was paus­ing pro­duc­tion at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Sanofi to pay $125M up­front for two im­munol­o­gy drugs from lit­tle-known biotech

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Ex­clu­sive: VelaV­i­go inks an­oth­er US biotech deal as Chi­na drug de­vel­op­ment scene booms

Sarep­ta los­es CMO to RNA edit­ing up­start; An­oth­er wave of per­son­nel moves at Dyne

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times